Clinical Trial Update: A Double-blind, Placebo-controlled Study of the Safety and Efficacy of Paliperidone Extended Release (ER) in the Treatment of Schizophrenia in Adolescent Patients [Phase 3]

View source ↗

Summary

A Phase 3 double-blind, placebo-controlled trial evaluated the safety and efficacy of paliperidone extended-release in adolescents with schizophrenia; results w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Paliperidone ER (paliperidone)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Schizophrenia | Phase 3 | Status: COMPLETED | Results posted: 2010-06-09